AmbioPharm
CAREERS   
中文
  • THE API MODEL
  • WHO WE SERVE
  • PEPTIDE PRODUCTS & SERVICES
    • GMP Services
      • GMP Manufacturing
      • Custom Peptide Synthesis
      • Custom Organic Synthesis
      • Biologically Active Peptides
    • Non-GMP Services
    • Vaccine Services
    • Cosmetic Peptide Manufacturing
    • Analytical Development & Validation
  • Quality & Systems
    • Quality & Compliance
    • FDA Inspection History
  • Resources
    • Webcasts & Presentations
    • Newsroom
    • Events
    • Blog
    • FAQs
  • About Us
    • Management Team
    • Manufacturing Facilities
    • Corporate Values
    • Green Peptide Chemistry
  • Contact Us
  • Careers
  • WEBCASTS & PRESENTATIONS
  • NEWSROOM
  • EVENTS
  • BLOG

Tag: biologicsUK

NextGen Biomed

March 8, 2019

READ ARTICLE

SETTING A NEW STANDARD

For Peptide API Manufacturing and Services


Have a Peptide project?

SUBMIT YOUR REQUIREMENTS
  • AmbioPharm

    Setting a New Standard for Peptide API Manufacturing and Services

    • The API Model
    • Who We Serve
    • Peptide Products & Services
    • Quality & Systems
    • Resources
    • About Us
    • Careers
    • Corporate Values
    • Contact Us
    • For Employees
    • EEO Law
  • CALL US +1 (803) 442-7590 CONTACT US
  • Copyright © 2026 AmbioPharm Inc.  |  Sitemap |  Privacy Policy |  Cookie Policy
  • Fraud Alert Notice

    Fraud Alert Notice

    We have been made aware of a fraudulent website operating under the domain ambiopharmpeptides.com.

    Please be advised that this website is not affiliated with, authorized by, or associated with our company in any way.

    Any communications, transactions, or claims made through this site are unauthorized and should be treated as potentially fraudulent.

    To protect yourself:

    • Do not provide personal or financial information to this website
    • Do not place orders or engage in business through this domain
    • Verify all communications directly with our official channels

    We are actively working to address this issue.